You just read:

MimiVax LLC and Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. announce exclusive licensing agreement on SurVaxM for glioblastoma treatment in China

News provided by

MimiVax, LLC

Nov 18, 2019, 05:00 ET